Covid nasal spray could be next leap in coronavirus vaccine development
2 years, 8 months ago

Covid nasal spray could be next leap in coronavirus vaccine development

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. open image in gallery Omicron persisted despite vaccinations "I don’t feel the research establishment should buy into we’ve solved this, and we will give you boosters of the current vaccine," said Larry Corey, a virologist at the Fred Hutchinson Cancer Research Center in Seattle. President Biden’s National Covid-19 Preparedness Plan, unveiled in March, emphasises the need to reboot vaccines to match variants within 100 days of their emergence and to develop a universal vaccine, one "that protects against Covid-19 and all its variants, as well as future emerging coronavirus threats." "We could Operation Warp Speed the next-generation mucosal vaccines, but we don’t have funding to do it," said Karin Bok, director of Pandemic Preparedness and Emergency Response at the National Institute of Allergy and Infectious Diseases. Then, before the omicron variant’s surge last year, Wagner heard about a scientific trial at Cincinnati Children’s Hospital Medical Centre of a nasal spray vaccine aimed at stopping the spread of the virus.

Infectious Diseases Vaccines Variants Covid Transmission Scientists Health Check Wagner Variant Omicron Nasal Seder Vaccinated People Nasal Vaccines Coronavirus Vaccine  variant  omicron  coronavirus  vaccine  covid  spray  vaccines  scientists  development  variants  virus  leap  transmission  nasal

History of this topic

The new COVID vaccine is out — but you might not want to rush to get it
4 months, 1 week ago

The new COVID vaccine is out — but you might not want to rush to get it

Raw Story  

The FDA has approved an updated covid shot for everyone 6 months old and up, which renews a now-annual quandary for Americans: Get the shot now, with the latest covid outbreak sweeping the country, or hold it in reserve for the winter wave? “Covid is still very transmissible, very new, and people congregate inside in air-conditioned rooms during the summer,” …

Does frequently updating COVID-19 vaccines have any benefits? | Explained
10 months, 3 weeks ago

Does frequently updating COVID-19 vaccines have any benefits? | Explained

The Hindu  

Researchers update the composition of influenza vaccines every six months to match the strains of the virus that are circulating in the wild, so that the shots may provide protective immunity against the flu. The VE of COVID-19 vaccines varies according to the disease’s progression as well as the circulating strains. Thus, researchers worldwide rushed to revise COVID-19 vaccines that …

Do special nasal sprays work to protect you from COVID?
1 year ago

Do special nasal sprays work to protect you from COVID?

Slate  

We’re in the fourth holiday season in which COVID is a reality that we have to deal with—and while most protective measures have disappeared from public view, some people are trying new approaches to avoid getting sick. One of these tools I’m seeing more and more on social media is nasal sprays of all types, with some influencers suggesting the …

COVID fourth dose might not work if…, expert on how to tackle new variant surge
1 year, 8 months ago

COVID fourth dose might not work if…, expert on how to tackle new variant surge

Live Mint  

The COVID-19 pandemic has brought about many challenges, one of which is the emergence of new variants of the virus that can evade immunity conferred by existing vaccines. While booster doses can still reduce the severity of the disease, experts are of the opinion that it may be time for governments to start thinking about second-generation vaccines. And, one of …

Centre rolls out first nasal Covid vaccine as booster
1 year, 11 months ago

Centre rolls out first nasal Covid vaccine as booster

Hindustan Times  

India on Thursday rolled out the first nasal vaccine against Covid-19, to be administered as a primary or booster dose for adults, potentially widening the pool of people who may take a third vaccine against the infection, cutting tertiary costs, and easing pressures on supply and storage networks. “Being the world’s first intranasal Covid-19 vaccine, this marks a glorious tribute …

Nasal vaccines to roll out in private hospitals soon
2 years ago

Nasal vaccines to roll out in private hospitals soon

Hindustan Times  

A new coronavirus vaccine used as a nasal spray will only be available at private health facilities and the Co-WIN platform was set to be tweaked on Friday to allow people to immediately begin booking shots, people aware of the matter said on Friday. On Thursday, India’s technical expert committee on immunization— National Technical Advisory Group on Immunisation —recommended the …

Bharat Biotech’s nasal vaccine on CoWIN app today: All you need to know
2 years ago

Bharat Biotech’s nasal vaccine on CoWIN app today: All you need to know

Live Mint  

Bharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry as a booster dose for those aged 18 years and above and is likely to be introduced on the Co-WIN platform Friday evening. What is the new nasal vaccine developed by Bharat Biotech? This vaccine candidate was evaluated in phase I, II and III clinical trials with …

As COVID-19 spikes in California, booster shots could make all the difference
2 years, 1 month ago

As COVID-19 spikes in California, booster shots could make all the difference

LA Times  

With coronavirus cases and hospitalizations rising in Los Angeles County, officials are voicing new confidence in the effectiveness of the updated COVID-19 booster shot. New data has found that the updated COVID-19 vaccines offer “significant additional protection” against symptomatic infection in people who were previously vaccinated or boosted with the older formula. “We have seen very low uptake of the …

Bharat Biotech’s nasal covid vax gets CDSCO’s nod as heterologous booster
2 years, 1 month ago

Bharat Biotech’s nasal covid vax gets CDSCO’s nod as heterologous booster

Live Mint  

Pharma firm Bharat Biotech on Monday announced that its intranasal covid-19 vaccine iNCOVACC has received approval from the Central Drugs Standard Control Organization for people above 18 years of age as a heterologous booster dose under restricted emergency use in India. With this development, INCOVACC becomes world’s first intranasal vaccine to receive both primary series and heterologous booster approval, the …

Covid vaccination improves effectiveness of treatment for cancer in nose-throat cavity
2 years, 2 months ago

Covid vaccination improves effectiveness of treatment for cancer in nose-throat cavity

The Independent  

Cancer drugs worked better after patients had had Covid-19 jabs, scientists have discovered. Patients with nasopharyngeal cancer – in the area from the back of the nose to the upper part of the throat – who had had a coronavirus vaccine “responded significantly better” to treatment than unvaccinated patients, according to German and Chinese experts. They were surprised when the …

High Hopes for Nasal Covid Vaccines Despite 'Disappointing' AstraZeneca Trial
2 years, 2 months ago

High Hopes for Nasal Covid Vaccines Despite 'Disappointing' AstraZeneca Trial

News 18  

Nasal vaccines could still be a powerful future weapon in the fight against Covid-19 despite “disappointing” recent trial results for an AstraZeneca spray, experts say. Eric Tartour, an immunologist at the European Hospital Georges Pompidou in Paris, said that while the AstraZeneca results “are indeed disappointing”, he did not think the news “dampens hope for nasal vaccines”. However, the vaccine …

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial
2 years, 2 months ago

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial

News 18  

In a major setback, AstraZeneca and the University of Oxford’s joint trial for the nasal-spray version of the Nonreplicating viral vector vaccine against Covid-19 did not yield desired protection, reported Reuters on Tuesday. The University of Oxford said, “An antibody response in the respiratory mucous membranes was seen in only a minority of participants in the trial, which was in …

What is a COVID-19 nasal vaccine?
2 years, 3 months ago

What is a COVID-19 nasal vaccine?

The Hindu  

Since the launch of its COVID-19 vaccine programme in early 2021, India has protected millions at home and abroad from the virus. The Hyderabad-based Bharat Biotech, the makers of Covaxin, has got an approval for its nasal vaccine from the Central Drugs Standard Control Organisation. It is for primary immunisation against COVID-19 in the 18-plus age group, for restricted use …

Explained | How does a COVID-19 nasal vaccine work?
2 years, 3 months ago

Explained | How does a COVID-19 nasal vaccine work?

The Hindu  

The story so far: On September 6, Union Health Minister Mansukh Mandaviya tweeted that the Central Drugs Standard Control Organisation had approved Bharat Biotech’s nasal vaccine for primary immunisation against COVID-19 in the 18-plus age group for restricted use in an emergency situation. A nasal vaccine is delivered through the nose or mouth and it is expected to work on …

Bharat Biotech’s intra-nasal COVID vaccine gets emergency use approval
2 years, 4 months ago

Bharat Biotech’s intra-nasal COVID vaccine gets emergency use approval

The Hindu  

Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 recombinant nasal vaccine has been approved by Central Drugs Standard Control Organisation for primary immunization against COVID-19 in 18+ age group for restricted use in emergencies, Health Minister Mansukh Mandaviya tweeted on Tuesday. Dr. Krishna Ella, chairman and managing director, Bharat Biotech, said: “iNCOVACC will be a global game changer in intra-nasal vaccines technology and delivery …

India's First Nasal Vaccine for Covid-19, Made by Bharat Biotech, Cleared for Emergency Use
2 years, 4 months ago

India's First Nasal Vaccine for Covid-19, Made by Bharat Biotech, Cleared for Emergency Use

News 18  

Bharat Biotech has been given an emergency use authorisation by India’s drug regulator, the Drug Controller General of India, for its intranasal Covid-19 vaccine, Union Health Minister Dr Mansukh Mandaviya tweeted on Tuesday. Big Boost to India's Fight Against COVID-19!Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for restricted …

Nasal vaccine: A futuristic intervention in immunisation drive
2 years, 4 months ago

Nasal vaccine: A futuristic intervention in immunisation drive

Firstpost  

Nasal vaccines are easier to administer, especially it would be a great relief for people who are afraid of needles and for children and the elderly population as it is non-invasive The world is slowly moving ahead of the deadly COVID-19 pandemic with the mass vaccination approach. However, recently, the nasal vaccine has been in the limelight as it can …

Bharat Biotech expects regulator’s nod for intranasal COVID-19 vaccine this month
2 years, 5 months ago

Bharat Biotech expects regulator’s nod for intranasal COVID-19 vaccine this month

The Hindu  

Bharat Biotech, which is working on an intranasal COVID-19 vaccine candidate is hopeful of getting regulatory licenses this month, if all goes well, Chairman and Managing Director of the company, Krishna Ella said. Clinical trials of nasal vaccine complete Mr. Ella said the firm completed clinical trials of the nasal vaccine with about 4,000 volunteers and there is no instance …

Nasal Sprays Will Be Essential to Tackle Covid-19 Variants, Study Says
2 years, 5 months ago

Nasal Sprays Will Be Essential to Tackle Covid-19 Variants, Study Says

News 18  

Intranasal vaccines for COVID-19 will be critical to protect people against the emerging variants of concern of the SARS-CoV-2 virus, according to a study. “Our data showed that mRNA vaccination also did not induce sufficient tissue-residing cellular immunity in the airways, another arm of our immune system to prevent the entry of the virus into our bodies,” he added. “The …

Covid nasal spray reduces viral load by 94% in 24 hours, 99% in 48 hours: Lancet Study
2 years, 5 months ago

Covid nasal spray reduces viral load by 94% in 24 hours, 99% in 48 hours: Lancet Study

India TV News  

Highlights Nasal spray administered in high-risk adult COVID-19 patients reduces viral load The phase 3 trial results have been published in Lancet Study The study on Nitric Oxide Nasal Spray was conducted by Mumbai-based pharmaceutical company Covid Nasal Spray: A nasal spray administered in high-risk adult COVID-19 patients in India reduced viral load by 94 per cent within 24 hours …

Will Americans have the right COVID-19 vaccine this fall? Maybe
2 years, 5 months ago

Will Americans have the right COVID-19 vaccine this fall? Maybe

LA Times  

A man walks underneath the marquee of the Alex Theatre in Glendale. Determining which recipe should go into those doses to induce optimal protection — the vaccine’s “composition” — is an exercise in educated guesswork. Getting a timely and accurate fix on all this “is truly a challenge, and it is science at its hardest,” Dr. Peter Marks, the U.S. …

FDA grapples with whether to modify COVID vaccine for fall
2 years, 6 months ago

FDA grapples with whether to modify COVID vaccine for fall

LA Times  

The Food and Drug Administration will debate Tuesday whether it’s time to update COVID vaccine formulas. “This is science at its toughest,” said FDA vaccine chief Dr. Peter Marks, adding that a final decision is expected within days of the advisory panel’s recommendation. In an analysis prepared for Tuesday’s meeting, FDA officials acknowledged targeting last winter’s version of Omicron is …

New oral Covid vaccine can decrease severity, transmission: Study
2 years, 8 months ago

New oral Covid vaccine can decrease severity, transmission: Study

India Today  

An investigational Covid vaccine designed to be administered orally has not only limited the degree of the disease but also decreased its airborne spread during its trial on animals, revealed a study published in the journal, Science Translational Medicine, earlier this week. The research team led by Duke University researcher Stephanie N Langel, a medical instructor in the Department of …

Nasal COVID-19 vaccine trials held at Vizag Institute
2 years, 8 months ago

Nasal COVID-19 vaccine trials held at Vizag Institute

Deccan Chronicle  

Visakhapatnam: The Visakha Institute of Medical Science hosted the third phase of the clinical trial of Covid-19 intranasal vaccine here on Saturday. VIMS is the only hospital in Andhra Pradesh among 17 locations in the country to have the trials of the Covid-19 nasal vaccine that is meant for people who have never got vaccinated so far. VIMS director Dr …

Nasal spray for adults at risk of severe Covid-19 launched
2 years, 11 months ago

Nasal spray for adults at risk of severe Covid-19 launched

Hindustan Times  

Mumbai-based pharma company Glenmark Pharmaceuticals on Wednesday announced the launch of a nasal spray for adults at high risk of severe Covid-19 after an approval from India’s drugs regulator, following clinical trials that the company said showed encouraging results. NONS has shown to reduce viral load by 94% in 24 hours in local clinical trials, the company said The product …

Multivariant Covid vaccine booster shows promise, early data suggests
3 years ago

Multivariant Covid vaccine booster shows promise, early data suggests

Deccan Chronicle  

London: A COVID-19 vaccine booster aimed at tackling multiple coronavirus variants shows promise in inducing a comprehensive immune response, early data suggests. The initial phase one clinical data shows the vaccine has strong levels of neutralising antibodies, similar to approved mRNA vaccines, but at up to a 10-fold lower dose in the first 10 individuals. "These initial data with samRNA …

Multivariant Covid vaccine booster shows promise, early data suggests
3 years ago

Multivariant Covid vaccine booster shows promise, early data suggests

India Today  

A Covid-19 vaccine booster aimed at tackling multiple coronavirus variants shows promise in inducing a comprehensive immune response, early data suggests. The initial phase one clinical data shows the vaccine has strong levels of neutralising antibodies, similar to approved mRNA vaccines, but at up to a 10-fold lower dose in the first 10 individuals. "These initial data with samRNA Covid …

UK scientists trial first needle-free air-powered COVID-19 vaccine
3 years ago

UK scientists trial first needle-free air-powered COVID-19 vaccine

Live Mint  

Scientists at the University of Cambridge on Tuesday began a clinical trial of a needle-free air-powered vaccine, which is expected to help combat future variants of COVID-19. "It’s vital that we continue to develop new generation vaccine candidates ready to help keep us safe from the next virus threats. Immunisation arms our immune system to look out for and block …

Experts Predict What COVID Vaccines Might Be Like In The Future
3 years, 1 month ago

Experts Predict What COVID Vaccines Might Be Like In The Future

Huff Post  

Francesco Carta fotografo via Getty Images When the mRNA vaccines rolled out at the end of 2020, we were told it would be quick and simple to tweak the shots should new variants of concern appear. Even with omicron — a variant that may potentially chip away at the effectiveness of our shots to a degree — the original vaccines’ …

New wave of coronavirus infections next autumn seems unavoidable, experts say
3 years, 1 month ago

New wave of coronavirus infections next autumn seems unavoidable, experts say

NL Times  

Medical experts told NOS that a spike in coronavirus infections next fall is likely despite an increasing number of people fully vaccinated against Covid-19. Extra measures, such as face masks, to stop the spread of the coronavirus will continue to be part of daily life, the experts said. Yet, the experts said that additional measures to prevent the spread of …

From Merck’s Molnupiravir to Glenmark’s nasal spray, over 20 new drugs in pipeline for COVID-19
3 years, 3 months ago

From Merck’s Molnupiravir to Glenmark’s nasal spray, over 20 new drugs in pipeline for COVID-19

Firstpost  

While the market for these drugs may not be huge at present due to a drop in COVID-19 cases and extended timelines, experts believe that these drugs will help control future waves and protect people with weak immunity Merck’s Molnupiravir, Zydus’ antibody cocktail and Glenmark’s nasal spray are among more than 20 new drugs in different stages of drug trials …

Merck’s Molnupiravir, Glenmark’s Nasal Spray, Zydus' Antibody Cocktail: 20+ Drugs in Pipeline for Covid
3 years, 3 months ago

Merck’s Molnupiravir, Glenmark’s Nasal Spray, Zydus' Antibody Cocktail: 20+ Drugs in Pipeline for Covid

News 18  

Merck’s Molnupiravir, Zydus’ antibody cocktail and Glenmark’s nasal spray are among more than 20 new drugs in different stages of drug trials or approvals in India to treat Covid-19. “As the world needs Covid-19 vaccines, the world also needs proven and effective Covid-19 therapies,” Lahariya said. List of Drugs in the Pipeline US pharma giant Merck and Ridgeback Biotherapeutics’ oral …

EXPLAINED: Alpha To Delta, One Shot To Beat Them All. Why Multivariant Jabs Could Be Future Of Covid Fight
3 years, 3 months ago

EXPLAINED: Alpha To Delta, One Shot To Beat Them All. Why Multivariant Jabs Could Be Future Of Covid Fight

News 18  

New and emerging variants of the novel coronavirus are seen as being able to dodge antibodies acquired either through vaccination or prior infection. While updated vaccines and additional shots are an option to counter potential future outbreaks — much like how existing vaccines are updated against the seasonal influenza — a single jab that is targeted towards multiple variants can …

Coronavirus update: Latest Covid-19 vaccine and US reopening news
3 years, 3 months ago

Coronavirus update: Latest Covid-19 vaccine and US reopening news

CNN  

The current evidence on Covid-19 vaccines does not appear to support a need for booster shots in the general public right now, according to an international group of vaccine scientists, including some from the US Food and Drug Administration and the World Health Organization. The FDA and other public health agencies around the world continue to examine evidence on Covid-19 …

Common questions about coronavirus vaccinations
3 years, 5 months ago

Common questions about coronavirus vaccinations

China Daily  

Here are answers to some of the most common questions about COVID-19 vaccines: Should older adults get the vaccine? It is not recommended to terminate pregnancy or delay pregnancy plans due to receiving vaccines, and pregnant women who are vaccinated should stick to routine prenatal visits and checks. For those getting two-dose inactivated vaccines, the first and second doses should …

Nasal Covid Vaccine Prevents Disease, Transmission in Animals: Study
3 years, 5 months ago

Nasal Covid Vaccine Prevents Disease, Transmission in Animals: Study

News 18  

A new single-dose, intranasal COVID-19 vaccine fully protects mice against lethal infection, and also blocks transmission of the SARS-CoV-2 virus in ferrets, a study has shown. “If this new COVID-19 vaccine proves effective in people, it may help block SARS-CoV-2 transmission and help control the COVID-19 pandemic,” McCray, co-leader of the study, said. “Our preclinical data show that this vaccine …

Nasal Covid vaccine prevents disease, transmission in animals, finds study
3 years, 5 months ago

Nasal Covid vaccine prevents disease, transmission in animals, finds study

India Today  

A new single-dose, intranasal Covid-19 vaccine fully protects mice against lethal infection, and also blocks transmission of the SARS-CoV-2 virus in ferrets, a study has shown. "If this new Covid-19 vaccine proves effective in people, it may help block SARS-CoV-2 transmission and help control the Covid-19 pandemic," McCray, co-leader of the study, said. "Our preclinical data show that this vaccine …

Nasal spray designed from engineered antibody could treat Covid-19, boost efficacy: Report
3 years, 7 months ago

Nasal spray designed from engineered antibody could treat Covid-19, boost efficacy: Report

India Today  

As the second wave of Covid-19 recedes, countries are rushing to vaccinate their people to protect vulnerable groups with some experts anticipating a third wave of the pandemic. A study published in journal Nature stated that nasal spray of a designer antibody offers strong protection against variants of coronavirus in mice. The engineered antibody managed to reduce the amount of …

Phase 1 Trials for Covid-19 Nasal Vaccines Are Underway, Says Bharat Biotech MD
3 years, 8 months ago

Phase 1 Trials for Covid-19 Nasal Vaccines Are Underway, Says Bharat Biotech MD

News 18  

India’s daily coronavirus death toll passed a new record on Saturday as the government battled to get oxygen supplies to hospitals overwhelmed by the lakhs of fresh daily cases. Talking to Republic Tv, Bharat Biotech MD Dr Krishna Ella talked about the possibility of a nasal vaccine for Coronavirus. Further emphasizing that Bharat Biotech could be the first one in …

Common questions about coronavirus vaccinations
3 years, 8 months ago

Common questions about coronavirus vaccinations

China Daily  

Here are answers to some of the most common questions about COVID-19 vaccines: Should older adults get the vaccine? It is not recommended to terminate pregnancy or delay pregnancy plans due to receiving vaccines, and pregnant women who are vaccinated should stick to routine prenatal visits and checks. For those getting two-dose inactivated vaccines, the first and second doses should …

Common questions about coronavirus vaccinations
3 years, 8 months ago

Common questions about coronavirus vaccinations

China Daily  

Here are answers to some of the most common questions about COVID-19 vaccines: Should older adults get the vaccine? It is not recommended to terminate pregnancy or delay pregnancy plans due to receiving vaccines, and pregnant women who are vaccinated should stick to routine prenatal visits and checks. For those getting two-dose inactivated vaccines, the first and second doses should …

Common questions about coronavirus vaccinations
3 years, 8 months ago

Common questions about coronavirus vaccinations

China Daily  

Here are answers to some of the most common questions about COVID-19 vaccines: Should older adults get the vaccine? It is not recommended to terminate pregnancy or delay pregnancy plans due to receiving vaccines, and pregnant women who are vaccinated should stick to routine prenatal visits and checks. For those getting two-dose inactivated vaccines, the first and second doses should …

Common questions about coronavirus vaccinations
3 years, 8 months ago

Common questions about coronavirus vaccinations

China Daily  

Here are answers to some of the most common questions about COVID-19 vaccines: Should older adults get the vaccine? It is not recommended to terminate pregnancy or delay pregnancy plans due to receiving vaccines, and pregnant women who are vaccinated should stick to routine prenatal visits and checks. For those getting two-dose inactivated vaccines, the first and second doses should …

Better covid vaccines are coming, WHO’s chief scientist says
3 years, 9 months ago

Better covid vaccines are coming, WHO’s chief scientist says

Live Mint  

New Covid-19 vaccines, including ones that don’t require needles and can be stored at room temperature, may be ready for use later this year or next year, the World Health Organization’s top scientist said. Six-to-eight new immunizations may complete clinical studies and undergo regulatory review by the end of the year, Soumya Swaminathan, the Geneva-based agency’s chief scientist, said in …

10 persons given nasal Covid-19 vaccine in Hyderabad, phase-1 trial at other centres soon
3 years, 10 months ago

10 persons given nasal Covid-19 vaccine in Hyderabad, phase-1 trial at other centres soon

India Today  

Ten volunteers shortlisted for the phase-1 clinical trial of intranasal Covid-19 vaccine, developed by Bharat Biotech, have received shots in Hyderabad. The last of the 10 shortlisted volunteer was given the intranasal Covid-19 vaccine shot on Wednesday. The phase-1 trial of the nasal Covid-19 vaccine will soon be held in Patna, Chennai and Nagpur. Phase 1 of the clinical trial …

COVID-19 vaccines may be tweaked if emerging coronavirus variants worsen, spread
3 years, 10 months ago

COVID-19 vaccines may be tweaked if emerging coronavirus variants worsen, spread

Firstpost  

The WHO and FDA are looking to the global flu vaccine system to make decisions around the COVID-19 shots. But studies are raising concern that first-generation COVID-19 vaccines don’t work as well against a mutant that first emerged in South Africa as they do against other versions circulating around the world. “This is a moving target right now.” Flu offers …

WHO recognises 'concerning news' of COVID-19 vaccines not working against variants
3 years, 11 months ago

WHO recognises 'concerning news' of COVID-19 vaccines not working against variants

Firstpost  

Booster shots will likely be needed, since new virus variants are spreading globally and likely to become the predominant strains. The head of the World Health Organization said Monday the emergence of new COVID-19 variants has raised questions about whether or not existing vaccines will work, calling it “concerning news” that the vaccines developed so far may be less effective …

Study finds COVID-19 vaccine may reduce virus transmission
3 years, 11 months ago

Study finds COVID-19 vaccine may reduce virus transmission

Associated Press  

AstraZeneca’s COVID-19 vaccine shows a hint that it may reduce transmission of the virus and offers strong protection for three months on just a single dose, researchers said Wednesday in an encouraging turn in the campaign to suppress the outbreak. In the United States, Dr. Anthony Fauci, the nation’s top infectious disease expert, dismissed the idea of deliberately delaying second …

Novavax COVID-19 vaccine works, but less so against variants
3 years, 11 months ago

Novavax COVID-19 vaccine works, but less so against variants

Associated Press  

Novavax Inc. said Thursday that its COVID-19 vaccine appears 89% effective based on early findings from a British study and that it The announcement comes amid worry about whether a variety of vaccines being rolled out around the world will be strong enough to protect against worrisome new variants – and as the world desperately needs new types of shots …

Discover Related